Table 1.
Characteristics | Receiving
1,25 (OH)2 D or analog (n = 49) |
Not Receiving
1,25 (OH)2 D or analog (n = 30) |
P
value |
||
---|---|---|---|---|---|
Age, years | 49 | 55 ± 1.8 | 30 | 56 ± 2.5 | 0.83 |
Gender | 49 | 31 M (63%) / 18 F | 30 | 19 M (63%) / 11 F | 0.99 |
Race/ethnicity n (%) | 49 | 30 | 0.59 | ||
African American | 20 (60%) | 17 (58%) | |||
Filipino | 7 (15%) | 3 (10%) | |||
Asian | 7 (15%) | 3 (10%) | |||
Hispanic | 4 (8%) | 5 (16%) | |||
Caucasian | 1 (2%) | 2 (6%) | |||
Body Weight kg | 49 | 75.5 ± 3.2 | 30 | 74.6 ± 3.4 | 0.85 |
BMI, kg/m2 | 49 | 28 ± 1 | 30 | 26 ± 1 | 0.37 |
Comorbid Conditions n (%) | 49 | 30 | |||
Hypertension | 45 (93%) | 28 (93%) | 0.80 | ||
Diabetes Mellitus | 21 (43%) | 18 (58%) | 0.14 | ||
Coronary Artery Disease | 22 (45%) | 13 (43%) | 0.99 | ||
Peripheral Vascular Disease | 8 (17%) | 2 (6%) | 0.21 | ||
Dialysis Vintage, months** | 49 | 25 (3, 288) | 30 | 30 (4, 152) | 0.98 |
Kt/V | 49 | 1.37 ± 0.04 | 29 | 1.46 ± 0.27 | 0.20 |
Serum albumin, mg/dL | 49 | 4.00 ± 0.06 | 29 | 3.79 ± 0.09 | 0.04 |
Hemoglobin g/dL | 49 | 11.9 ± 0.2 | 29 | 11.8 ± 0.3 | 0.95 |
Serum urea nitrogen, mmol/L (mg/dL) | 49 | 21± 0.7 (59 ± 2.0) | 29 | 22 ± 1.2 (63 ± 3.5) | 0.29 |
Serum creatinine, μmol/L (mg/dL) | 49 | 887.6 ± 37.7 (10.0 ± 0.4) | 28 | 936.1 ± 48.8 (10.6 ± 0.6) | 0.38 |
Serum calcium, mmol/L (mg/dL) | 49 | 2.31 ± 0.02 (9.2 ± 0.09) | 29 | 2.27 ± 0.05 (9.1 ± 0.18) | 0.60 |
Serum phosphorous, mmol/L(mg/dL), | 49 | 1.99 ± 0.11 (6.2 ± 0.3) | 29 | 1.81 ± 0.10 (5.6 ± 0.3) | 0.27 |
Serum alkaline phosphatase, units/L | 48 | 134 ± 26 | 28 | 115 ± 12 | 0.66 |
Intact parathyroid hormone, ng/L (pg/ml)** | 43 | 309 (56,1482) | 24 | 230 (37,1435) | 0.26 |
Laboratory results reported in SI units with conventional units in parentheses. Data presented as the mean ± SEM except ** which are reported as the median (minimum,maximum) because of non-normal distribution